The Active Approach to Antimicrobial Resistance: How Self-Propagating Genetics Could Erase AMR

Introduction: The Silent Pandemic of Antimicrobial Resistance

In the grand calculus of global health, few variables are as threatening as the rise of antimicrobial resistance (AMR). For nearly a century, humanity has relied on a "passive" pharmacological strategy: the administration of chemical compounds designed to inhibit or kill bacteria. While this approach has saved countless lives, it has inevitably driven an evolutionary arms race. Bacteria, under the selective pressure of antibiotics, have evolved sophisticated resistance mechanisms, often encoded on mobile genetic elements known as plasmids. These plasmids act as biological ferries, transporting resistance genes between different bacterial species and turning harmless environmental microbes into reservoirs of incurable disease.

The scale of this threat is staggering. Epidemiological models project that without significant intervention, AMR could claim up to 10 million lives annually by the year 2050, potentially surpassing cancer as a leading cause of global mortality.¹ The central challenge lies not merely in killing the bacteria—chemical disinfectants can do that—but in neutralizing the genetic information that makes them resistant. Traditional antibiotics leave the genetic "blueprint" of resistance intact in the environment, ready to be picked up by the next generation of pathogens.

In February 2026, a collaborative team of researchers from the University of California, San Diego (UCSD), published a landmark study in npj Antimicrobials and Resistance that proposes a radical shift in strategy. Led by Saluja Kaduwal, alongside principal investigators Ethan Bier and Justin R. Meyer, the team introduced "Pro-Active Genetics" (Pro-AG), a self-propagating genetic system designed to actively seek out and overwrite antibiotic resistance genes within bacterial populations.¹ This technology represents a transition from passive chemical warfare to active genetic engineering, employing the very mechanisms bacteria use to spread resistance to instead spread a cure.

The Architecture of Pro-Active Genetics

The theoretical foundation of Pro-AG is derived from "gene drives," a technology originally developed to bias inheritance in sexually reproducing organisms like mosquitoes to combat malaria. In a typical gene drive, a genetic element copies itself from one chromosome to another, ensuring it is inherited by nearly all offspring. The UCSD team faced a unique challenge: bacteria reproduce asexually, meaning they do not have the chromosomal pairing required for traditional gene drives. To overcome this, the researchers adapted the concept for plasmids—the circular DNA molecules that bacteria swap during conjugation (mating).⁴

The Genetic Vehicle: pPro-MobV

The core of the Pro-AG system is a specifically engineered plasmid designated pPro-MobV. This construct is a masterpiece of synthetic biology, combining three distinct functional modules to create an autonomous "search-and-destroy" machine.

The first module is the vector backbone, derived from the pBBR1 origin of replication. Unlike the high-copy-number plasmids typically used in laboratory cloning, pBBR1 maintains a medium copy number. Crucially, it possesses a broad host range, meaning it can replicate in a wide variety of Gram-negative bacteria—including Pseudomonas, Klebsiella, and Salmonella—rather than being limited to Escherichia coli. This design choice ensures that the therapeutic agent can function across the diverse microbial communities found in real-world infections or sewage systems.⁵

The second module is the conjugation machinery, adapted from the IncP RK2 plasmid system. This machinery functions as the engine of the system, encoding the Type IV secretion system—effectively a molecular syringe—that allows the bacterium to actively pump the Pro-AG plasmid into neighboring cells. This motility is essential for the system to spread through a population rather than treating only a single cell.⁶

The third and most critical module is the CRISPR-Cas drive element. This cassette contains the gene for the Cas9 nuclease (the "scissors"), a single guide RNA (sgRNA) that targets a specific antibiotic resistance gene (in this study, the bla gene conferring Ampicillin resistance), and "homology arms." These homology arms are DNA sequences identical to the regions flanking the resistance gene in the target plasmid.

The Mechanism: Search, Cut, and Copy

The Pro-AG system operates through a sophisticated "mutagenic chain reaction" (MCR) adapted for prokaryotes. When a donor bacterium carrying pPro-MobV conjugates with a recipient bacterium carrying an antibiotic resistance plasmid (such as pETas), the following molecular cascade is initiated:

1. Invasion: The Pro-AG plasmid enters the recipient cell via the conjugal bridge.

2. Targeting: The Cas9 nuclease, guided by the sgRNA, locates the resistance gene (bla) on the recipient's plasmid.

3. Cleavage: Cas9 induces a double-strand break (DSB) specifically within the resistance gene.

4. The Drive (Homology-Directed Repair): In a standard CRISPR interference scenario, this cut would lead to the degradation of the plasmid. However, the Pro-AG system provides a "repair template" via its homology arms. The bacterial repair machinery (specifically the RecA pathway) uses this template to repair the break. Because the template contains the Pro-AG cassette itself, the repair process copies the Pro-AG system into the target plasmid.⁷

The result is a "positive feedback loop." The target plasmid loses its resistance gene (insertional inactivation) and gains the Pro-AG machinery. This newly converted plasmid now produces more Cas9 and gRNA, amplifying the effect and potentially converting other plasmids within the same cell.

Experimental Efficacy and the RecA Paradox

To validate this system, the UCSD researchers conducted extensive trials using Escherichia coli models. They utilized E. coli strain EPI300 as the donor and E. coli MG1655 as the recipient. The experiments involved mixing these populations and incubating them under specific conditions (typically 72 hours at 30 degrees Celsius with agitation) to encourage conjugation.⁶

Quantitative Success

The results demonstrated a dramatic reduction in antibiotic resistance. The Pro-AG system achieved an approximate 5-log reduction in Ampicillin-resistant colony-forming units (CFU). This represents a 100,000-fold decrease in the resistant population. When compared to control methods that utilized standard CRISPR-Cas9 (which cuts but does not copy/drive), the Pro-AG system was found to be approximately 100 times more efficient.³

Performance in Biofilms

A particularly significant finding was the system's efficacy within biofilms. Biofilms are structured communities of bacteria encased in a protective extracellular matrix, commonly found on medical implants (like catheters) and in industrial water systems. These structures are notoriously impervious to chemical antibiotics, which often fail to penetrate the matrix. The study showed that because the Pro-AG system is "living" and motile (via conjugation), it could infiltrate the biofilm lattice and neutralize resistance genes in bacteria that would otherwise be unreachable.¹

The Role of Recombination Pathways

The study uncovered a fascinating nuance regarding the role of RecA, the bacterial protein responsible for homologous recombination. The researchers compared the system's performance in wild-type (RecA-positive) bacteria versus RecA-deficient mutants.

Bacterial Strain Type	Mechanism Dominance	Outcome
RecA+ (Wild Type)	Homology-Directed Repair (HDR)	The system successfully "copies" the Pro-AG cassette into the target plasmid. This allows the drive to propagate but preserves the plasmid backbone.
RecA- (Deficient)	Failed Repair / Degradation	The Cas9 cut cannot be repaired via recombination. The linearized plasmid is exposed to exonucleases (like RecBCD) and is rapidly destroyed.

Counter-intuitively, the suppression of resistance was actually higher (by roughly 100-fold) in the RecA-deficient strains.⁶ In the absence of repair, the target plasmid is simply obliterated. While this maximizes the immediate "cure" of the individual cell, it halts the "drive" mechanism, preventing the modified plasmid from spreading to new cells. This finding suggests a trade-off: RecA is necessary for the spread of the therapy through a population, while RecA-deficiency maximizes the sterilization of the individual bacterium.

The Safeguard: Homology-Based Deletion

The deployment of self-propagating genetic elements raises significant ethical and ecological concerns. A "living drug" that spreads autonomously could theoretically escape the targeted treatment zone and modify environmental microbial communities in unforeseen ways. Addressing this risk was a primary objective of the Kaduwal et al. study. The team developed a "scrubbing" mechanism known as Homology-Based Deletion (HBD) to render the system reversible.⁹

The HBD Mechanism

Homology-Based Deletion acts as a programmable self-destruct switch for the Pro-AG cassette. The researchers designed the Pro-AG cassette to be flanked by short "direct repeats"—identical sequences of DNA placed at both ends of the construct. The study utilized specific repeat lengths, notably 75 base pairs and 17 base pairs.⁶

To activate this safeguard, a secondary genetic signal (such as a different gRNA delivered by a phage) directs Cas9 to cut the DNA specifically between these direct repeats. Upon cleavage, the identical sequences at the exposed ends anneal to one another. This results in the precise excision of the genetic material between the repeats (the Pro-AG cassette), leaving behind only a single "scar" of the repeat sequence. This process effectively deletes the genetic engineering tool from the bacterium, restoring it to a near-native state (minus the antibiotic resistance gene, which was destroyed in the previous step).

The researchers demonstrated that this HBD process is robust and, unlike the drive mechanism, functions efficiently even in RecA-deficient backgrounds.⁹ This suggests that the deletion relies on simpler repair mechanisms, such as Single-Strand Annealing (SSA), making it a reliable safety valve across different bacterial genetic backgrounds.

Phage Delivery: The "Chaser"

To implement this in a real-world scenario, the researchers envision a two-phase treatment protocol. First, the Pro-AG bacteria are introduced to spread the "cure" for antibiotic resistance. Once the resistance genes have been neutralized, a "chaser" treatment is applied using engineered bacteriophages (viruses that infect bacteria), such as the lambda-DPro-AG phage.³ These phages inject the HBD components into the bacteria, triggering the deletion of the Pro-AG cassette. This ensures that no genetically modified drive elements persist in the environment after the treatment is concluded.

Discussion: The Future of Microbiome Engineering

The implications of the Pro-AG system extend far beyond the petri dish. By establishing a proof-of-principle for active genetic editing in bacterial populations, this study opens new avenues for microbiome engineering.

Current antibiotic therapies are often compared to "carpet bombing"; they indiscriminately kill both pathogens and the beneficial commensal bacteria that constitute our microbiome, often leading to secondary infections (such as C. difficile) and long-term health issues. Pro-AG represents a "sniper" approach. It allows for the selective disarming of harmful genes without killing the bacteria themselves. This could preserve the delicate ecological balance of the gut microbiome while removing the specific virulence factors that threaten patient health.

Furthermore, the technology holds immense promise for environmental remediation. Wastewater treatment plants and agricultural runoff zones are currently hotspots for the evolution of "superbugs." The introduction of Pro-AG-equipped bacteria into these reservoirs could actively degrade resistance plasmids in the sludge, reducing the load of dangerous genetics released into natural waterways.¹¹

However, the path from the laboratory to the clinic remains steep. Regulatory bodies like the FDA and EPA have stringent guidelines regarding the release of genetically modified organisms (GMOs), particularly those designed to spread autonomously. The successful characterization of the HBD safety switch is a critical step toward meeting these regulatory standards, but rigorous containment trials will be required to ensure the system does not jump to non-target species.

Conclusion

The 2026 study by Kaduwal, Bier, and Meyer marks a pivotal moment in the fight against antimicrobial resistance. It demonstrates that we need not be passive victims of bacterial evolution. By co-opting the very mechanisms of horizontal gene transfer that bacteria use to weaponize themselves, Pro-Active Genetics turns the pathogen's strength into its vulnerability. While challenges in delivery and regulation persist, the ability to "edit" a bacterial population—to scrub it of resistance while leaving the community intact—offers a hopeful glimpse into a post-antibiotic era where genetic precision replaces chemical brute force.

Works cited

1. Next Generation Genetics Technology Developed to Counter the Rise of Antibiotic Resistance - UC San Diego Today, accessed February 7, 2026, https://today.ucsd.edu/story/next-generation-genetics-technology-developed-to-counter-the-rise-of-antibiotic-resistance

2. Future Bioterror and Biowarfare Threats - Marine Corps University, accessed February 7, 2026, https://www.usmcu.edu/Outreach/Marine-Corps-University-Press/MCU-Journal/JAMS-vol-14-no-1/Future-Bioterror-and-Biowarfare-Threats/

3. A conjugal gene drive-like system efficiently suppresses antibiotic ..., accessed February 7, 2026, https://pubmed.ncbi.nlm.nih.gov/41629533/

4. CRISPR-Cas-Based Antimicrobials: Design, Challenges, and Bacterial Mechanisms of Resistance | ACS Infectious Diseases, accessed February 7, 2026, https://pubs.acs.org/doi/10.1021/acsinfecdis.2c00649

5. Agarose gel electrophoresis analysis of HindIII-digested fosmid clones before and after conjugation from E. coli S17-1 to P. fluorescens - ResearchGate, accessed February 7, 2026, https://www.researchgate.net/figure/Agarose-gel-electrophoresis-analysis-of-HindIII-digested-fosmid-clones-before-and-after_fig1_260527214

6. | Efficient reduction of Amp R CFU and recovery on Sm plates ..., accessed February 7, 2026, https://www.researchgate.net/figure/Efficient-reduction-of-Amp-R-CFU-and-recovery-on-Sm-plates-following-transfer-of-Pro-AG_fig2_400383573

7. The Pro-AG system mediates efficient editing and cargo delivery... - ResearchGate, accessed February 7, 2026, https://www.researchgate.net/figure/The-Pro-AG-system-mediates-efficient-editing-and-cargo-delivery-dependent-on-precise_fig3_337956514

8. (PDF) Viral gene drive in herpesviruses - ResearchGate, accessed February 7, 2026, https://www.researchgate.net/publication/344423323_Viral_gene_drive_in_herpesviruses

9. Microbiome - ESP.ORG, accessed February 7, 2026, http://www.esp.org/recommended/literature/microbiome/

10. A conjugal gene drive-like system efficiently suppresses antibiotic resistance in a bacterial population - PMC, accessed February 7, 2026, https://pmc.ncbi.nlm.nih.gov/articles/PMC12864801/

11. Optimization of the Quantification of Antibiotic Resistance Genes in Media from the Yangtze River Estuary - ResearchGate, accessed February 7, 2026, https://www.researchgate.net/publication/400377558_Optimization_of_the_Quantification_of_Antibiotic_Resistance_Genes_in_Media_from_the_Yangtze_River_Estuary